September 23, 2014 3:31 AM ET

Biotechnology

Company Overview of PeptiVir, Inc.

Executive Profile

Richard C. Duke Ph.D.

Scientific Founder and Member of Scientific Advisory Board, GlobeImmune Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Richard C. Duke, Ph.D. Co-Founded of ApopLogic Pharmaceuticals LLC in 2006 and serves as its President and Chief Executive Officer. Dr. Duke serves as Corporate Director of VetDC, Inc. Dr. Duke has been Chairman and Acting Chief Executive Officer of PeptiVir, Inc. since 2010. He is involved in the formation of Sierra Neuropharmaceuticals, Newellink and MenoGeniX. He has been Scientific Founder of GlobeImmune, Inc. since 1996. He is Founder and Chief Scientific Officer ...

Corporate Headquarters

12635 East Montview Boulevard
Aurora, Colorado 80045

United States

Phone: 720-859-4046
Fax: 720-859-4044

Board Members Memberships

Scientific Founder and Member of Scientific Advisory Board
Vice Chairperson
Corporate Director
Director and Strategic Advisor
2010-Present
Chairman and Acting Chief Executive Officer

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PeptiVir, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.